The endocannabinoid system is modulated in response to spinal cord injury in rats.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neurobiology of Disease

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2008.09.015PMID 18930143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endocannabinoid-mediated neuron-astrocyte communication

  2009cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Spinal Microglial and Perivascular Cell Cannabinoid Receptor Type 2 Activation Reduces Behavioral Hypersensitivity without Tolerance after Peripheral Nerve Injury

  2008cited by this paper
• STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

  2008cited by this paper
• Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury

  2008cited by this paper
• Training locomotor networks.

  2008cited by this paper
• Effects of Palmitoylethanolamide on Signaling Pathways Implicated in the Development of Spinal Cord Injury

  2008influential reference
• Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

  2008influential reference
• Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus

  2008cited by this paper
• A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol

  2007cited by this paper
• The orphan receptor GPR55 is a novel cannabinoid receptor

  2007influential reference
• Glial cell loss, proliferation and replacement in the contused murine spinal cord

  2007cited by this paper
• Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17β‐estradiol

  2007influential reference
• Long-Term Plasticity of the Spinal Locomotor Circuitry Mediated by Endocannabinoid and Nitric Oxide Signaling

  2007cited by this paper
• The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury.

  2007influential reference
• Spinal cord injury medicine. 1. Epidemiology and classification.

  2007cited by this paper
• Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats.

  2007influential reference
• Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post‐natal rats through cannabinoid receptor 1 and cannabinoid receptor 2

  2007cited by this paper
• Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.

  2007cited by this paper
• Update on the treatment of spinal cord injury.

  2007cited by this paper
• CB2 cannabinoid receptors promote mouse neural stem cell proliferation

  2007cited by this paper
• Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol.

  2007influential reference
• Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis

  2007cited by this paper
• Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved

  2007cited by this paper
• Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.

  2007cited by this paper
• Prominent oligodendrocyte genesis along the border of spinal contusion lesions

  2007influential reference
• Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury

  2006influential reference
• Immune-Based Therapy for Spinal Cord Repair: Autologous Macrophages and Beyond

  2006cited by this paper
• The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

  2006cited by this paper
• The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.

  2006cited by this paper
• Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.

  2006cited by this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cited by this paper
• Protective activation of the endocannabinoid system during ischemia in dopamine neurons.

  2006cited by this paper
• Experimental strategies to promote spinal cord regeneration--an integrative perspective.

  2006influential reference
• Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice

  2006influential reference
• Therapeutic interventions after spinal cord injury

  2006cited by this paper
• Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.

  2006cited by this paper
• Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor.

  2006cited by this paper
• The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines.

  2006cited by this paper
• Endocannabinoids potently protect the newborn brain against AMPA‐kainate receptor‐mediated excitotoxic damage

  2006cited by this paper
• Spinal cord repair strategies: why do they work?

  2006cited by this paper
• NG2 Colocalizes With Axons and Is Expressed by a Mixed Cell Population in Spinal Cord Lesions

  2006influential reference
• Functional plasticity following spinal cord lesions.

  2006cited by this paper
• Plasticity of connections underlying locomotor recovery after central and/or peripheral lesions in the adult mammals

  2006cited by this paper
• The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

  2005cited by this paper
• Cannabinoid-based drugs as anti-inflammatory therapeutics

  2005influential reference
• Dual Modulation of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Protects against Excitotoxicity

  2005influential reference
• Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair.

  2005cited by this paper
• The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

  2005cited by this paper
• Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis

  2005cited by this paper
• Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat.

  2005cited by this paper
• The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.

  2005cited by this paper
• Cell proliferation and replacement following contusive spinal cord injury

  2005cited by this paper
• The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide

  2005cited by this paper
• Olig2 Directs Astrocyte and Oligodendrocyte Formation in Postnatal Subventricular Zone Cells

  2005cited by this paper
• Neuromodulation via conditional release of endocannabinoids in the spinal locomotor network.

  2005cited by this paper
• Spinal cord injury is accompanied by chronic progressive demyelination

  2005cited by this paper
• Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons.

  2005cited by this paper
• Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis

  2005influential reference
• CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition.

  2005influential reference
• Synthetic cannabinoid WIN55,212‐2 inhibits generation of inflammatory mediators by IL‐1β‐stimulated human astrocytes

  2005influential reference
• Motoneuron Loss Associated with Chronic Locomotion Impairments after Spinal Cord Contusion in the Rat

  2005cited by this paper
• Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.

  2005influential reference
• CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition

  2005cited by this paper
• Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

  2005cited by this paper
• Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia.

  2004influential reference
• P2X7 receptors control 2-arachidonoylglycerol production by microglial cells.

  2004influential reference
• A Global Perspective on Spinal Cord Injury Epidemiology

  2004cited by this paper
• Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners*

  2004influential reference
• Cellular transplantation strategies for spinal cord injury and translational neurobiology

  2004cited by this paper
• Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids.

  2004cited by this paper
• Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels.

  2004cited by this paper
• Functional disassociation of the central and peripheral fatty acid amide signaling systems.

  2004influential reference
• Patterns of Gene Expression Reveal a Temporally Orchestrated Wound Healing Response in the Injured Spinal Cord

  2004cited by this paper
• Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury

  2004cited by this paper
• CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity

  2003influential reference
• A Novel Neuroimmune Mechanism in Cannabinoid-mediated Attenuation of Nerve Growth Factor–induced Hyperalgesia

  2003cited by this paper
• Spinal cord injury medicine.

  2003cited by this paper
• Endogenous Interleukin-1 Receptor Antagonist Mediates Anti-Inflammatory and Neuroprotective Actions of Cannabinoids in Neurons and Glia

  2003influential reference
• Blood‐spinal cord barrier after spinal cord injury: Relation to revascularization and wound healing

  2003cited by this paper
• Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor

  2003cited by this paper
• Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

  2003cited by this paper
• Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

  2003cited by this paper
• Endothelin‐1 increases 2‐arachidonoyl glycerol (2‐AG) production in astrocytes

  2003cited by this paper
• Upregulation of spinal cannabinoid‐1‐receptors following nerve injury enhances the effects of Win 55,212‐2 on neuropathic pain behaviors in rats

  2003cited by this paper
• Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility

  2003cited by this paper
• Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

  2003cited by this paper
• Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide‐induced nitric oxide release in astrocyte cultures

  2002influential reference
• Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study.

  2002cited by this paper
• Cell death in models of spinal cord injury.

  2002influential reference
• Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.

  2002cited by this paper
• Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord.

  2002cited by this paper
• Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling

  2002influential reference
• Brain monoglyceride lipase participating in endocannabinoid inactivation

  2002cited by this paper
• Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway*

  2002cited by this paper
• Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat

  2002cited by this paper
• Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic Transmission

  2002influential reference
• Endocannabinoids control spasticity in a multiple sclerosis model

  2001influential reference

• Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models.

  2025cites this paper
• Dual Role of the Spinal Endocannabinoid System in Response to Noxious Stimuli: Antinociceptive Pathways and Neuropathic Pain Mechanisms

  2025cites this paper
• Maladaptive changes in the homeostasis of AEA-TRPV1/CB1R induces pain-related hyperactivity of nociceptors after spinal cord injury

  2025influential citation
• Cannabinoid Receptor 2 (CB2) in Macrophages: A Promising Clinical Target for Immune Disorders

  2025cites this paper
• Spinal cord injury induces transient activation of hepatic stellate cells in rat liver

  2025cites this paper
• Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain.

  2024cites this paper
• Astrocytic Dagla Deletion Decreases Hedonic Feeding in Female Mice

  2024cites this paper
• Improvement of lower urinary tract dysfunction by a monoacylglycerol lipase inhibitor in mice with spinal cord injury

  2024cites this paper
• Selective blockade of cannabinoid receptors influence motoneuron survival and glial reaction after neonatal axotomy.

  2024cites this paper
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

  2024cites this paper
• Microglial Cannabinoid CB2 Receptors in Pain Modulation

  2023cites this paper
• Cannabinoids in Periodontology: Where Are We Now?

  2023cites this paper
• Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model

  2023cites this paper
• Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation

  2022cites this paper
• Endocannabinoid signaling in oligodendroglia

  2022influential citation
• Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.

  2022cites this paper
• Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Human and Rat Spinal Cord Tissue

  2022cites this paper
• Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

  2022cites this paper
• G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential

  2021cites this paper
• Systematic review of the impact of cannabinoids on neurobehavioral outcomes in preclinical models of traumatic and nontraumatic spinal cord injury

  2021influential citation
• NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI).

  2021cites this paper
• 2‐arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions

  2020cites this paper
• Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors

  2020cites this paper
• Impacts of epidural electrical stimulation on Wnt signaling, FAAH, and BDNF following thoracic spinal cord injury in rat

  2020cites this paper
• Exogenous activation of cannabinoid-2 receptor modulates TLR4/MMP9 expression in a spinal cord ischemia reperfusion rat model

  2020cites this paper
• An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events

  2020cites this paper
• A Feasible Method for Quantifying Living Pancreatic Human Islets in Murine Livers Posttransplantation by Confocal Laser Scanning Microscopy

  2020cites this paper
• Long‐term application of cannabinoids leads to dissociation between changes in cAMP and modulation of GABAA receptors of mouse trigeminal sensory neurons

  2019cites this paper
• Inhibiting a spinal cord signaling pathway protects against ischemia injury in rats

  2019cites this paper
• Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect

  2018cites this paper
• The Endocannabinoid System and Oligodendrocytes in Health and Disease

  2018cites this paper
• Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells

  2018cites this paper
• The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis

  2018cites this paper
• Inhibition of platelet aggregation by vanilloid-like agents: investigation of possible mechanisms

  2017cites this paper
• Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation

  2017cites this paper
• Electroacupuncture pretreatment attenuates spinal cord ischemia-reperfusion injury via inhibition of high-mobility group box 1 production in a LXA4 receptor-dependent manner.

  2017cites this paper
• The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner.

  2017cites this paper
• Endocannabinoid Turnover.

  2017cites this paper
• Remote Ischemia Preconditioning Attenuates Blood-Spinal Cord Barrier Breakdown in Rats Undergoing Spinal Cord Ischemia Reperfusion Injury: Associated with Activation and Upregulation of CB1 and CB2 Receptors

  2017cites this paper
• Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system

  2017cites this paper
• Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB2 Receptors

  2016cites this paper
• A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro.

  2016cites this paper
• Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease.

  2016cites this paper
• Type-2 cannabinoid receptors in neurodegeneration.

  2016cites this paper
• Cannabinoids to treat spinal cord injury.

  2016cites this paper
• Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation

  2016cites this paper
• Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration

  2016cites this paper
• Anatomical Characterization of the Type-1 cannabinoid receptors in specific brain cell populations of mutant mice

  2016cites this paper
• Evolution of the diacylglycerol lipases.

  2016cites this paper
• Changes of endocannabinoid plasma levels following type I trauma : A prospective pilot study

  2016cites this paper
• Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury‐Induced Immunodeficiency Syndrome

  2016influential citation
• Time-Dependent Protection of CB2 Receptor Agonist in Stroke

  2015cites this paper
• Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea[S]

  2015cites this paper
• CB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: A possible mechanism of improved recovery.

  2015cites this paper
• Isolevuglandin Adducts in Disease

  2015cites this paper
• Cannabinoides: utilidad actual en la práctica clínica

  2015cites this paper
• Microcirculation of the brain: morphological assessment in degenerative diseases and restoration processes

  2015cites this paper
• RESVERATROL: MORE THAN A PHYTOCHEMICAL

  2015cites this paper
• Fatty Acid Amide Hydrolase (FAAH) Inhibitors Exert Pharmacological Effects, but Lack Antinociceptive Efficacy in Rats with Neuropathic Spinal Cord Injury Pain

  2014cites this paper
• Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation

  2014cites this paper
• Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury.

  2014cites this paper
• Remote Neurodegeneration: Multiple Actors for One Play

  2014cites this paper
• Palmitoylethanolamide in CNS health and disease.

  2014cites this paper
• Synaptic effects of cannabinoids

  2014cites this paper
• Cannabinoids and the brain: New hopes for new therapies

  2014cites this paper
• Discovery of the Endocannabinoid System: A Breakthrough in Neuroscience

  2014cites this paper
• Does the Neuroprotective Role of Anandamide Display Diurnal Variations?

  2013cites this paper
• Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury.

  2013cites this paper
• Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma.

  2013cites this paper
• Endocannabinoids and N-acylethanolamines in translational pain research : from monoacylglycerol lipase to muscle pain

  2013cites this paper
• A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord

  2013cites this paper
• Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D

  2013cites this paper
• Endocannabinoid signaling in Alzheimer’s disease: current knowledge and future directions.

  2013cites this paper
• The role of endocannabinoids in pain modulation

  2013cites this paper
• Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries.

  2013cites this paper
• Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator

  2013cites this paper
• Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells

  2013cites this paper
• The neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects

  2013cites this paper
• Effects of Se-phenyl thiazolidine-4-carboselenoate on mechanical and thermal hyperalgesia in brachial plexus avulsion in mice: mediation by cannabinoid CB1 and CB2 receptors.

  2012cites this paper
• Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide

  2012cites this paper
• Investigating the role of the endogenous cannabinoid system in emotional modulation of pain: neurochemical and molecular mechanisms

  2012cites this paper
• Changes of endocannabinoid plasma levels following type I trauma

  2012cites this paper
• Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system

  2012cites this paper
• CD200‐CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation

  2012cites this paper
• Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage

  2012cites this paper
• Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery

  2012influential citation
• Long-term treatment with methanandamide attenuates LPS-induced periodontitis in rats

  2012cites this paper
• CB1 receptor antagonism/inverse agonism increases motor system excitability in humans.

  2012cites this paper
• Changes of endocannabinoid plasma levels following type I trauma: A prospective pilot study

  2012cites this paper
• Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury

  2012influential citation
• New Targets in Pain, Non-Neuronal Cells, and the Role of Palmitoyletha- nolamide

  2012cites this paper
• A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion

  2012cites this paper
• The Cannabinoid 1 Receptor and Progenitor Cells in the Adult Central Nervous System

  2012cites this paper
• 5 The Cannabinoid 1 Receptor and Progenitor Cells in the Adult Central Nervous System

  2012cites this paper
• EPIGENETIC MECHANISMS IN ALZHEIMER'S DISEASE: STATE-OF-THE-ART

  2012cites this paper
• Molecular Sites for the Positive Allosteric Modulation of Glycine Receptors by Endocannabinoids

  2011cites this paper
• Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury.

  2011cites this paper
• Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.

  2011cites this paper
• Palmitoylethanolamide Protects Dentate Gyrus Granule Cells via Peroxisome Proliferator-Activated Receptor-Alpha

  2011cites this paper
• Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization.

  2011cites this paper